Hasil Pencarian - Peter Atadja
- Menampilkan 1 - 8 hasil dari 8
-
1
ING1 and 5-azacytidine act synergistically to block breast cancer cell growth. oleh Satbir Thakur, Xiaolan Feng, Zhong Qiao Shi, Amudha Ganapathy, Manoj Kumar Mishra, Peter Atadja, Don Morris, Karl Riabowol
Diterbitkan 2012-01-01Dapatkan teks lengkap
Artikel -
2
Concurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expression. oleh Leigh Ellis, Kristin Lehet, Swathi Ramakrishnan, Remi Adelaiye, Kiersten M Miles, Dan Wang, Song Liu, Peter Atadja, Michael A Carducci, Roberto Pili
Diterbitkan 2011-01-01Dapatkan teks lengkap
Artikel -
3
Involvement of histone acetylation of Sox17 and Foxa2 promoters during mouse definitive endoderm differentiation revealed by microRNA profiling. oleh Shijun Fu, Qi Fei, Hua Jiang, Shannon Chuai, Song Shi, Wen Xiong, Lei Jiang, Chris Lu, Peter Atadja, En Li, Jianyong Shou
Diterbitkan 2011-01-01Dapatkan teks lengkap
Artikel -
4
Polycomb target genes are silenced in multiple myeloma. oleh Antonia Kalushkova, Mårten Fryknäs, Miguel Lemaire, Charlotte Fristedt, Prasoon Agarwal, Maria Eriksson, Sarah Deleu, Peter Atadja, Anders Osterborg, Kenneth Nilsson, Karin Vanderkerken, Fredrik Oberg, Helena Jernberg-Wiklund
Diterbitkan 2010-07-01Dapatkan teks lengkap
Artikel -
5
Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of a Novel Histone Deacetylase Inhibitor, LAQ824, in Human Colon Carcinoma Cells and Xenografts oleh Yuen-Li Chung, Helen Troy, Rebecca Kristeleit, Wynne Aherne, L. Elizabeth Jackson, Peter Atadja, John R. Griffiths, Ian R. Judson, Paul Workman, Martin O. Leach, Mounia Beloueche-Babari
Diterbitkan 2008-04-01Dapatkan teks lengkap
Artikel -
6
FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion oleh Yichao Fan, Jiao Yue, Mengtao Xiao, Han Han-Zhang, Yao Vickie Wang, Chun Ma, Zhilin Deng, Yingxiang Li, Yanyan Yu, Xinghao Wang, Shen Niu, Youjia Hua, Zhiping Weng, Peter Atadja, En Li, Bin Xiang
Diterbitkan 2017-08-01Dapatkan teks lengkap
Artikel -
7
In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma oleh Enrique M. Ocio, David Vilanova, Peter Atadja, Patricia Maiso, Edvan Crusoe, Diego Fernández-Lázaro, Mercedes Garayoa, Laura San-Segundo, Teresa Hernández-Iglesias, Enrique de Álava, Wenlin Shao, Yung-Mae Yao, Atanasio Pandiella, Jesús F. San-Miguel
Diterbitkan 2010-05-01Dapatkan teks lengkap
Artikel -
8
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED. oleh Ling Li, Hailong Zhang, Man Zhang, Mengxi Zhao, Lijian Feng, Xiao Luo, Zhenting Gao, Ying Huang, Ophelia Ardayfio, Ji-Hu Zhang, Ying Lin, Hong Fan, Yuan Mi, Guobin Li, Lei Liu, Leying Feng, Fangjun Luo, Lin Teng, Wei Qi, Johannes Ottl, Andreas Lingel, Dirksen E Bussiere, Zhengtian Yu, Peter Atadja, Chris Lu, En Li, Justin Gu, Kehao Zhao
Diterbitkan 2017-01-01Dapatkan teks lengkap
Artikel